Selective aldosterone receptor antagonist (SARA); structurally similar to spironolactone, q.v. Prepn: J. Grob, J. Kalvoda, EP 122232; eidem, US 4559332 (1984, 1985 both to Ciba-Geigy); J. Grob et al., Helv. Chim. Acta 80, 566 (1997). Pharmacology and receptor binding studies: M. de Gasparo et al., J. Pharmacol. Exp. Ther. 240, 650 (1987). Clinical pharmacokinetics: W. R. Ravis et al., J. Clin. Pharmacol. 45, 810 (2005). Clinical trial in congestive heart failure after myocardial infarction: B. Pitt et al., N. Engl. J. Med. 348, 1309 (2003); in hypertension vs losartan: M. H. Weinberger et al., Am. Heart J. 150, 426 (2005). Review of pharmacology and clinical experience: J. A. Delyani et al., Cardiovasc. Drug Rev. 19, 185-200 (2001); E. Burgess, Expert Opin. Pharmacother. 5, 2573-2581 (2004).
Antihypertensive. In treatment of congestive heart failure.
Aldosterone Antagonist; Antihypertensive